Literature DB >> 19158937

Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy.

Kenichi Oshima1, Dennis W Dickson.   

Abstract

Alzheimer disease (AD) is characterized by numerous senile plaques (SP) in addition to widespread neocortical neurofibrillary tangles (NFT). Some elderly have pathologic aging (PA), which is characterized by numerous SP composed of diffuse amyloid deposits with few or no NFT confined to the limbic lobe. Both AD and PA represent a range of Alzheimer type pathology (ATP). Some cases of progressive supranuclear palsy (PSP) have concurrent ATP, but the relationship between ATP and PSP has not been addressed. In this study, a consecutive series of PSP cases were divided into three groups according to the degree of concurrent ATP - pure PSP, PSP/PA and PSP/AD. Braak NFT stage was significantly greater in PSP/AD compared with both PSP/PA and PSP. Among the pathologic variables studied in middle frontal, superior temporal and motor cortices, there were no differences between PSP and PSP/PA except for SP. In PSP/AD, there was greater neuronal tau pathology (pretangles, NFT and neuropil threads) in middle frontal and superior temporal cortices, probably a reflection of ATP since there was no comparable increase in PSP-related glial tau pathology in these regions. The APOEvarepsilon4 allele frequency was significantly higher in PSP/PA and PSP/AD than in PSP. These results strongly argue that ATP in PSP represents independent disease processes even when present in the same brain.

Entities:  

Keywords:  Alzheimer's disease; apolipoprotein E; progressive supranuclear palsy; senile plaque; tau

Year:  2008        PMID: 19158937      PMCID: PMC2615597     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  45 in total

1.  Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.

Authors:  T Arai; K Ikeda; H Akiyama; Y Shikamoto; K Tsuchiya; S Yagishita; T Beach; J Rogers; C Schwab; P L McGeer
Journal:  Acta Neuropathol       Date:  2001-02       Impact factor: 17.088

2.  Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy.

Authors:  H R Morris; A Schrag; U Nath; D Burn; N P Quinn; S Daniel; N W Wood; A J Lees
Journal:  Neurosci Lett       Date:  2001-10-19       Impact factor: 3.046

3.  Lewy bodies in progressive supranuclear palsy represent an independent disease process.

Authors:  Hirotake Uchikado; Anthony DelleDonne; Zeshan Ahmed; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2006-04       Impact factor: 3.685

Review 4.  Coexistence of PSP and MSA: a case report and review of the literature.

Authors:  Hirotake Uchikado; Anthony DelleDonne; Ryan Uitti; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2006-02-03       Impact factor: 17.088

5.  Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E.

Authors:  Takashi Togo; Natalie Cookson; Dennis W Dickson
Journal:  Brain Pathol       Date:  2002-01       Impact factor: 6.508

6.  Mixed multiple system atrophy and progressive supranuclear palsy: a clinical and pathological report of one case.

Authors:  Masashi Takanashi; Satoshi Ohta; Shuji Matsuoka; Hideo Mori; Yoshikuni Mizuno
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

7.  Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.

Authors:  Takashi Togo; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2002-05-30       Impact factor: 17.088

Review 8.  Progressive supranuclear palsy: pathology and genetics.

Authors:  Dennis W Dickson; Rosa Rademakers; Michael L Hutton
Journal:  Brain Pathol       Date:  2007-01       Impact factor: 6.508

9.  Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease.

Authors:  Takashi Togo; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2002-04-09       Impact factor: 17.088

10.  APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.

Authors:  Yoshio Tsuboi; Keith A Josephs; Natalie Cookson; Dennis W Dickson
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

View more
  8 in total

1.  Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP?

Authors:  Virgilio Gerald H Evidente; Charles H Adler; Marwan N Sabbagh; Donald J Connor; Joseph G Hentz; John N Caviness; Lucia I Sue; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2011-03-21       Impact factor: 4.891

2.  Concomitant pathologies among a spectrum of parkinsonian disorders.

Authors:  Brittany N Dugger; Charles H Adler; Holly A Shill; John Caviness; Sandra Jacobson; Erika Driver-Dunckley; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2014-02-22       Impact factor: 4.891

3.  Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; J Eric Ahlskog; Nirubol Tosakulwong; Matthew L Senjem; Anthony J Spychalla; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2017-12-13       Impact factor: 4.891

4.  Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy.

Authors:  Brittany N Dugger; Michael Tu; Melissa E Murray; Dennis W Dickson
Journal:  Neurosci Lett       Date:  2011-01-12       Impact factor: 3.046

5.  Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.

Authors:  Alma Ghirelli; Nirubol Tosakulwong; Stephen D Weigand; Heather M Clark; Farwa Ali; Hugo Botha; Joseph R Duffy; Rene L Utianski; Marina Buciuc; Melissa E Murray; Sydney A Labuzan; Anthony J Spychalla; Nha Trang Thu Pham; Christopher G Schwarz; Matthew L Senjem; Mary M Machulda; Matthew Baker; Rosa Rademakers; Massimo Filippi; Clifford R Jack; Val J Lowe; Joseph E Parisi; Dennis W Dickson; Keith A Josephs; Jennifer L Whitwell
Journal:  Ann Neurol       Date:  2020-09-12       Impact factor: 10.422

6.  Typical or atypical progressive supranuclear palsy: a comparative clinicopathologic study of three Chinese cases.

Authors:  Ming-Wei Zhu; Jia Liu; Thomas Arzberger; Lu-Ning Wang; Zhen-Fu Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

7.  Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.

Authors:  Helen Ling; H Ling; R de Silva; L A Massey; R Courtney; G Hondhamuni; N Bajaj; J Lowe; J L Holton; A Lees; T Revesz
Journal:  Neuropathol Appl Neurobiol       Date:  2014-02       Impact factor: 8.090

8.  How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.

Authors:  Momoko Ebashi; Yoshinori Ito; Miho Uematsu; Ayako Nakamura; Katsuiku Hirokawa; Satoshi Kamei; Toshiki Uchihara
Journal:  Acta Neuropathol Commun       Date:  2019-05-06       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.